Phase II evaluation of etoposide in refractory multiple myeloma: a Southeastern Cancer Study Group Trial.
Publication
, Journal Article
Gockerman, JP; Bartolucci, AA; Nelson, MO; Silberman, H; Velez-Garcia, E; Stein, R
Published in: Cancer Treat Rep
June 1986
Duke Scholars
Published In
Cancer Treat Rep
ISSN
0361-5960
Publication Date
June 1986
Volume
70
Issue
6
Start / End Page
801 / 802
Location
United States
Related Subject Headings
- Podophyllotoxin
- Multiple Myeloma
- Middle Aged
- Male
- Humans
- Hematologic Diseases
- Female
- Etoposide
- Drug Evaluation
- Clinical Trials as Topic
Citation
APA
Chicago
ICMJE
MLA
NLM
Gockerman, J. P., Bartolucci, A. A., Nelson, M. O., Silberman, H., Velez-Garcia, E., & Stein, R. (1986). Phase II evaluation of etoposide in refractory multiple myeloma: a Southeastern Cancer Study Group Trial. Cancer Treat Rep, 70(6), 801–802.
Gockerman, J. P., A. A. Bartolucci, M. O. Nelson, H. Silberman, E. Velez-Garcia, and R. Stein. “Phase II evaluation of etoposide in refractory multiple myeloma: a Southeastern Cancer Study Group Trial.” Cancer Treat Rep 70, no. 6 (June 1986): 801–2.
Gockerman JP, Bartolucci AA, Nelson MO, Silberman H, Velez-Garcia E, Stein R. Phase II evaluation of etoposide in refractory multiple myeloma: a Southeastern Cancer Study Group Trial. Cancer Treat Rep. 1986 Jun;70(6):801–2.
Gockerman, J. P., et al. “Phase II evaluation of etoposide in refractory multiple myeloma: a Southeastern Cancer Study Group Trial.” Cancer Treat Rep, vol. 70, no. 6, June 1986, pp. 801–02.
Gockerman JP, Bartolucci AA, Nelson MO, Silberman H, Velez-Garcia E, Stein R. Phase II evaluation of etoposide in refractory multiple myeloma: a Southeastern Cancer Study Group Trial. Cancer Treat Rep. 1986 Jun;70(6):801–802.
Published In
Cancer Treat Rep
ISSN
0361-5960
Publication Date
June 1986
Volume
70
Issue
6
Start / End Page
801 / 802
Location
United States
Related Subject Headings
- Podophyllotoxin
- Multiple Myeloma
- Middle Aged
- Male
- Humans
- Hematologic Diseases
- Female
- Etoposide
- Drug Evaluation
- Clinical Trials as Topic